Nurix Therapeutics (NRIX) Income Statement (2019 - 2026)
Income Statement report data from Feb 28, 2019 to May 31, 2026 for Nurix Therapeutics (NRIX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||||||
Total Revenue | 9.04M (+44.64%) | 6.25M (-53.98%) | 14M (+72.12%) | 7.89M (-82.09%) | 44M (+138.81%) | 18M (+38.93%) | 13M (+5.48%) | 13M (+4.14%) | 12M (-27.12%) | 17M (+9.43%) | 15M (-17.92%) | 18M (-39.80%) | 31M (+141.77%) | 13M (+87.17%) | 6.78M (-37.16%) | 11M (-5.60%) | 11M (+18.81%) | 9.62M (+30.00%) | 7.40M (-27.80%) | 10M (+44.57%) | 7.09M (+41.52%) | 5.01M (-25.11%) | 6.69M (+63.57%) | 4.09M (-2.15%) | 4.18M (+46.15%) | 2.86M (-90.81%) | 31M | - | - | - |
Operating Expenses | ||||||||||||||||||||||||||||||
Research And Development | 88M (+4.17%) | 84M (+1.35%) | 83M (-3.60%) | 86M (+10.27%) | 78M (+12.12%) | 70M (+3.63%) | 67M (+21.16%) | 55M (+13.41%) | 49M (-2.18%) | 50M (+0.60%) | 50M (+3.87%) | 48M (+4.59%) | 46M (-0.13%) | 46M (-0.63%) | 46M (-3.45%) | 48M (+0.57%) | 47M (+10.08%) | 43M (+18.09%) | 37M (+18.18%) | 31M (+18.93%) | 26M (+13.00%) | 23M (+12.47%) | 20M (+7.97%) | 19M (+33.95%) | 14M (+9.02%) | 13M (-61.88%) | 34M (+208.99%) | 11M | - | - |
Selling General And Administrative | 16M (+6.71%) | 15M (+7.03%) | 14M (+3.72%) | 13M (-7.84%) | 14M (+22.58%) | 12M (+8.68%) | 11M (-8.53%) | 12M (+0.09%) | 12M (-0.76%) | 12M (+9.46%) | 11M (+1.51%) | 11M (-9.08%) | 12M (+18.94%) | 9.82M (+4.80%) | 9.37M (-3.90%) | 9.75M (+1.04%) | 9.65M (+4.55%) | 9.23M (+4.65%) | 8.82M (+5.76%) | 8.34M (+11.05%) | 7.51M (+15.01%) | 6.53M (+4.48%) | 6.25M (+44.01%) | 4.34M (+32.72%) | 3.27M (+33.47%) | 2.45M (-60.10%) | 6.14M (+181.65%) | 2.18M | - | - |
Operating Expenses | 103M (+4.56%) | 99M (+2.15%) | 97M (-2.63%) | 99M (+7.47%) | 92M (+13.60%) | 81M (+4.34%) | 78M (+15.98%) | 67M (+10.84%) | 61M (-1.89%) | 62M (+2.17%) | 60M (+3.44%) | 58M (+1.81%) | 57M (+3.24%) | 56M (+0.31%) | 55M (-3.55%) | 58M (+0.63%) | 57M (+9.13%) | 52M (+15.48%) | 45M (+15.54%) | 39M (+17.13%) | 34M (+13.48%) | 30M (+10.60%) | 27M (+14.69%) | 23M (+33.72%) | 17M (+12.91%) | 15M (-61.60%) | 40M (+204.47%) | 13M | - | - |
Depreciation And Amortization | - | 2.20M (-65.57%) | 6.39M | - | - | 2.35M (-67.68%) | 7.27M | - | - | 2.05M (-64.53%) | 5.78M | - | - | 1.75M (+12.18%) | 1.56M (+4.00%) | 1.50M (+15.38%) | 1.30M (+31.31%) | 990K (+16.47%) | 850K (+21.43%) | 700K (+16.67%) | 600K (-6.25%) | 640K (+8.47%) | 590K (-1.67%) | 600K (+20.00%) | 500K (+2.04%) | 490K (-72.00%) | 1.75M (+191.67%) | 600K | - | - |
Operating Income | ||||||||||||||||||||||||||||||
Operating Income | -94.20M (+1.85%) | -92.49M (+11.31%) | -83.09M (-9.07%) | -91.38M (+89.11%) | -48.32M (-23.13%) | -62.86M (-2.78%) | -64.66M (+18.40%) | -54.61M (+12.51%) | -48.54M (+7.34%) | -45.22M (-0.24%) | -45.33M (+13.30%) | -40.01M (+49.51%) | -26.76M (-37.69%) | -42.95M (-11.79%) | -48.69M (+4.22%) | -46.72M (+2.21%) | -45.71M (+6.95%) | -42.74M (+12.62%) | -37.95M (+30.86%) | -29.00M (+9.81%) | -26.41M (+7.71%) | -24.52M (+22.54%) | -20.01M (+4.27%) | -19.19M (+45.05%) | -13.23M (+5.42%) | -12.55M (-36.03%) | -19.62M (+651.72%) | -2.61M | - | - |
Ebit | -94.20M (+1.85%) | -92.49M (+11.31%) | -83.09M (-9.07%) | -91.38M (+89.11%) | -48.32M (-23.13%) | -62.86M (-2.78%) | -64.66M (+18.40%) | -54.61M (+12.51%) | -48.54M (+7.34%) | -45.22M (-0.24%) | -45.33M (+13.30%) | -40.01M (+49.51%) | -26.76M (-37.69%) | -42.95M (-11.79%) | -48.69M (+4.22%) | -46.72M (+2.21%) | -45.71M (+6.95%) | -42.74M (+12.62%) | -37.95M (+30.86%) | -29.00M (+9.81%) | -26.41M (+7.71%) | -24.52M (+22.54%) | -20.01M (+4.27%) | -19.19M (+45.05%) | -13.23M (+5.42%) | -12.55M (-9.52%) | -13.87M (+431.42%) | -2.61M (-14.98%) | -3.07M (+14.55%) | -2.68M |
EBITDA | -89.81M (-0.54%) | -90.30M (+3.45%) | -87.29M (+1.01%) | -86.42M (+102.39%) | -42.70M (-29.43%) | -60.51M (-9.96%) | -67.20M (+37.51%) | -48.87M (+9.92%) | -44.46M (+2.99%) | -43.17M (-4.22%) | -45.07M (+21.88%) | -36.98M (+52.31%) | -24.28M (-41.07%) | -41.20M (-12.58%) | -47.13M (+4.22%) | -45.22M (+1.82%) | -44.41M (+6.37%) | -41.75M (+12.50%) | -37.11M (+31.13%) | -28.30M (+9.65%) | -25.81M (+8.08%) | -23.88M (+22.97%) | -19.42M (+4.46%) | -18.59M (+46.03%) | -12.73M (+5.56%) | -12.06M (-0.50%) | -12.12M (+502.99%) | -2.01M (-34.53%) | -3.07M (+14.55%) | -2.68M |
Net Income | ||||||||||||||||||||||||||||||
Income Before Tax | -89.81M | - | -78.22M (-9.49%) | -86.42M (+102.39%) | -42.70M (-24.22%) | -56.35M (-3.74%) | -58.54M (+19.79%) | -48.87M (+9.92%) | -44.46M (+7.31%) | -41.43M (-1.26%) | -41.96M (+13.47%) | -36.98M (+52.31%) | -24.28M (-40.39%) | -40.73M (-12.82%) | -46.72M (+2.21%) | -45.71M (+0.68%) | -45.40M (+6.75%) | -42.53M (+12.93%) | -37.66M (+30.04%) | -28.96M (+10.37%) | -26.24M (+8.43%) | -24.20M (+21.79%) | -19.87M (+7.29%) | -18.52M (+42.35%) | -13.01M (+5.09%) | -12.38M (-34.98%) | -19.04M (+686.78%) | -2.42M | - | - |
Income Tax Expense | -270.00K | - | - | - | 760K | - | 10K (-87.50%) | 80K (-11.11%) | 90K (0.00%) | 90K | - | - | - | - | - | - | - | - | 40K | -120.00K | 140K (+100.00%) | 70K (+75.00%) | 40K | - | -20.59M | 10K (-95.65%) | 230K (+2200.00%) | 10K | - | - |
Net Income From Continuing Operations | -89.53M (+2.71%) | -87.17M (+11.44%) | -78.22M (-9.49%) | -86.42M (+98.85%) | -43.46M (-22.87%) | -56.35M (-3.76%) | -58.55M (+19.59%) | -48.96M (+9.90%) | -44.55M (+7.30%) | -41.52M (-1.05%) | -41.96M (+13.47%) | -36.98M (+52.31%) | -24.28M (-40.39%) | -40.73M (-12.82%) | -46.72M (+2.21%) | -45.71M (+0.68%) | -45.40M (+6.75%) | -42.53M (+12.81%) | -37.70M (+30.77%) | -28.83M (+9.29%) | -26.38M (+8.69%) | -24.27M (+21.90%) | -19.91M (+7.51%) | -18.52M | 7.58M | -12.39M (-8.36%) | -13.52M (+456.38%) | -2.43M (-20.85%) | -3.07M (+14.55%) | -2.68M |
Net Income | -89.53M (+2.71%) | -87.17M (+11.44%) | -78.22M (-9.49%) | -86.42M (+98.85%) | -43.46M (-22.87%) | -56.35M (-3.76%) | -58.55M (+19.59%) | -48.96M (+9.90%) | -44.55M (+7.30%) | -41.52M (-1.05%) | -41.96M (+13.47%) | -36.98M (+52.31%) | -24.28M (-40.39%) | -40.73M (-12.82%) | -46.72M (+2.21%) | -45.71M (+0.68%) | -45.40M (+6.75%) | -42.53M (+12.81%) | -37.70M (+30.77%) | -28.83M (+9.29%) | -26.38M (+8.69%) | -24.27M (+21.90%) | -19.91M (+7.51%) | -18.52M | 7.58M | -12.39M (-8.36%) | -13.52M (+456.38%) | -2.43M (-20.85%) | -3.07M (+14.55%) | -2.68M |
Comprehensive Income Net Of Tax | -89.74M (+2.89%) | -87.22M (-67.02%) | -264.50M (+206.56%) | -86.28M (+97.39%) | -43.71M (-22.32%) | -56.27M (-70.81%) | -192.76M (+297.61%) | -48.48M (+9.36%) | -44.33M (+7.57%) | -41.21M (-70.62%) | -140.28M (+286.34%) | -36.31M (+58.35%) | -22.93M (-42.18%) | -39.66M (-78.45%) | -184.07M (+296.96%) | -46.37M (-0.11%) | -46.42M (+5.52%) | -43.99M (-62.69%) | -117.89M (+307.64%) | -28.92M (+9.55%) | -26.40M (+8.60%) | -24.31M (-43.66%) | -43.15M (+132.99%) | -18.52M | 7.66M | -12.33M (-43.18%) | -21.70M (+793.00%) | -2.43M | - | - |